Update and validation of the lifetime cardiovascular risk in Spain: IBERLIFERISK2.
暂无分享,去创建一个
C. Brotons | M. Sánchez-Chaparro | Irene Moral-Peláez | Johanna Vicuña | Cristina Ameixeiras | Carlos Fernández-Lavandera
[1] Danielle M. Enserro,et al. Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study , 2022, Circulation.
[2] I. V. Van Gelder,et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.
[3] D. Fernández,et al. Effectiveness of an Intervention Aimed at Improving Information for Patients with High Cardiovascular Risk: INFORISK Clinical Trial , 2021, International journal of environmental research and public health.
[4] J. Boer,et al. Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people. , 2020, European heart journal.
[5] C. Brotons,et al. Estimación del riesgo cardiovascular de por vida (IBERLIFERISK): una herramienta nueva en prevención primaria de las enfermedades cardiovasculares , 2019, Revista Española de Cardiología.
[6] L. Ruilope,et al. Comparison of application of different methods to estimate lifetime cardiovascular risk , 2016, European journal of preventive cardiology.
[7] A. Zanchetti,et al. Estimating the glomerular filtration rate in the Spanish working population: chronic kidney disease prevalence and its association with risk factors , 2014, Journal of hypertension.
[8] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[9] Heart Protection Study Collaborative Group. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial , 2011, Lancet.
[10] Carol Coupland,et al. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database , 2010, BMJ : British Medical Journal.
[11] Ralph B D'Agostino,et al. Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age , 2006, Circulation.
[12] O. Aalen. Nonparametric Inference for a Family of Counting Processes , 1978 .